# The Holding Area LINQ (Reveal LINQ Insertable Cardiac Monitor) Trial is a Prospective, Non-randomized, Single Center Post-market Clinical Trial

> **NCT02493205** · — · COMPLETED · sponsor: **Holy Cross Hospital, Florida** · enrollment: 20 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02493205
- **Lead sponsor:** Holy Cross Hospital, Florida
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2016-06
- **Final completion:** 2016-11
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2022-01-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02493205

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02493205, "The Holding Area LINQ (Reveal LINQ Insertable Cardiac Monitor) Trial is a Prospective, Non-randomized, Single Center Post-market Clinical Trial". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02493205. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*